| scholarly article | Q13442814 |
| P2093 | author name string | R K Holmes | |
| A D O'Brien | |||
| J E Samuel | |||
| L P Perera | |||
| P2860 | cites work | Ribosome inactivation by ricin A chain: a sensitive method to assess the activity of wild-type and mutant polypeptides | Q24567536 |
| Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities | Q24646436 | ||
| Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 | ||
| Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860628 | ||
| Vero cytotoxin-producing strains of Escherichia coli | Q33449592 | ||
| Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis. | Q34372184 | ||
| Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits | Q36165342 | ||
| Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine | Q36215407 | ||
| Infection by verocytotoxin-producing Escherichia coli | Q36634680 | ||
| Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants | Q36977977 | ||
| Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies | Q36997934 | ||
| In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity | Q37006892 | ||
| Cloning of genes for production of Escherichia coli Shiga-like toxin type II | Q37007761 | ||
| Shiga and Shiga-like toxins | Q37063416 | ||
| Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay | Q37156797 | ||
| Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. | Q38349693 | ||
| Quantitative microtiter cytotoxicity assay for Shigella toxin. | Q40230921 | ||
| Role of glutamic acid 177 of the ricin toxin A chain in enzymatic inactivation of ribosomes | Q40651036 | ||
| An improved filamentous helper phage for generating single-stranded plasmid DNA. | Q44125783 | ||
| The primary structure of the operons coding for Shigella dysenteriae toxin and temperature phage H30 shiga-like toxin | Q48318734 | ||
| Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin. | Q54726146 | ||
| Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. | Q54764104 | ||
| The three-dimensional structure of ricin at 2.8 A | Q68962681 | ||
| Two distinct toxins active on Vero cells from Escherichia coli O157 | Q69870583 | ||
| Cytotoxic Escherichia coli O157:H7 associated with haemorrhagic colitis in Canada | Q72542036 | ||
| Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (SHIGA) like cytotoxin | Q72548803 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 829-835 | |
| P577 | publication date | 1991-03-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Mapping the minimal contiguous gene segment that encodes functionally active Shiga-like toxin II | |
| P478 | volume | 59 |
| Q39822350 | Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons | cites work | P2860 |
Search more.